1)lymphocyte transfusion淋巴细胞输注
英文短句/例句
1.The study on Haploidentical Related Donor Lymphocyte Infusion Versus High-risk Non-Hodgkin,s Lymphoma in Vitro;半相合供者淋巴细胞输注抗中、高危非霍奇金氏淋巴瘤的实验研究
2.Five patients with malignant hematonosis were received donor lymphocyte infusion(DLI) after transplantation.对5例恶性血液病实施供者淋巴细胞输注。
3.The latest advances of research on donor lymphocyte infusion in treatment of leukemia供者淋巴细胞输注研究在白血病治疗中的进展
4.Research on mouse treated with allo-BMT plus DLI post nonlethal preconditioning不同淋巴细胞输注对非清髓小鼠异基因骨髓干细胞移植的影响
5.Donor lymphocyte infusion is a therapeutic alternative for CML patients relapsed after transplantation.供者淋巴细胞输注是治疗移植后复发的有效方法。
6.Effect of heterogenous DLI on tumor-bearing mouse treated with allo-BMT不同成分淋巴细胞输注对荷瘤小鼠异基因骨髓移植的影响
7.Effect of Heterogenous DLI on Mouse Treated with Allo-BMT Post Nonlethal Preconditioning不同成分供者淋巴细胞输注对非清髓小鼠异基因骨髓移植的影响
8.An Experimental Study on the Effects of Sensitized-Donor Lymphocytes Infusion after Non-Myeloablative Allo-Stem Cell Transplantation;非清髓移植后致敏供者淋巴细胞输注的实验研究
9.Study of Donor Lymphocyte Infusion on the Treatment of Mouse H_(22) Transplanted Hepatocarcinoma;供者淋巴细胞输注治疗小鼠H_（22）肝癌皮下移植瘤的实验研究
10.The Clinical Study of HLA-haploidentical Lymphocyte Infusions for 59 Patients with Refractory Solid TumorsHLA半相合淋巴细胞输注治疗59例难治性实体瘤的临床分析
11.Influence of intra-bone marrow injection of donor lymphocytes upon the development of graft-versus-host disease不同途径的供者淋巴细胞输注对移植物抗宿主病的影响
12.Influence of intra-bone marrow injection with donor lymphocyte upon the development of graft-versus-host disease骨髓腔内供者淋巴细胞输注对移植物抗宿主病的影响
13.ObjectiveTo evaluate the efficacy and complications of donor lymphocyte infusion (DLI) following nonmyeloablative stem cell transplantation(NSCT)for the patients with hematologic diseases.【目的】研究非清髓性造血干细胞移植治疗血液病和供者淋巴细胞输注的疗效及并发症。
14.donor lymphocyte infusion (DLI) and induced graft versus host plasma cell effect can aslo be used in the treatment of delayed erythropoiesis.供者淋巴细胞输注及诱导移植物抗宿将细胞效应也可用于此类问题的治疗。
15.Effects of Donor Spleen Leukomonocytes Transfusion and FK506 on Cardiac Allo-transplantation in Mice during Acute Rejection;供体脾淋巴细胞输注及FK506对同种异体小鼠心脏移植急性排斥反应的影响
16.Effects of Hydroxyethyl Starch Infusion on Postoperative Changes in Immunity of T-lymphocyte in Gastric Cancer Patients Undergoing Surgery;胃癌根治术中输注羟乙基淀粉对T淋巴细胞的影响
17.Experimental Study on Immune Tolerance of Porcine Liver Transplantation Induced by Pre-infusion of Donor Apoptotic Lymphocyte;供体凋亡淋巴细胞预输注诱导猪肝移植免疫耐受的实验研究
18.A cell that gives rise to a mature lymphocyte.淋巴母细胞生成成熟淋巴细胞的细胞
相关短句/例句
Donor lymphocyte infusion供者淋巴细胞输注
1.To explore whether the complete donor chimerism could be achieved and graft-versus-host disease could be alleviated by donor lymphocyte infusion which was sensitized by the skin of the recipient, female C57BL/6 mice (H-2~b, B6) as recipients received total body irradiation (TBI) of 5.本研究目的是探讨经受者皮肤致敏后的异基因供者淋巴细胞输注(DLI)是否能在促进形成完全供者嵌合(CC)的同时减轻移植物抗宿主病(GVHD)。
2.Objective To explore the effect of donor lymphocyte infusion on H22 hepatoma mice.目的:观察供者淋巴细胞输注(DLI)对小鼠H2 2肝癌的治疗作用。
3.ObjectiveTo evaluate the efficacy and complications of donor lymphocyte infusion (DLI) following nonmyeloablative stem cell transplantation(NSCT)for the patients with hematologic diseases.【目的】研究非清髓性造血干细胞移植治疗血液病和供者淋巴细胞输注的疗效及并发症。
3)Donor lymphocyte infusion供体淋巴细胞输注
1.Tumor growth in mouse allogeneic chimeras and antitumor effects of donor lymphocyte infusion;异源嵌合体小鼠体内肿瘤生长情况及供体淋巴细胞输注的抗肿瘤反应
4)DLI供者淋巴细胞输注
1.2 weeks after NST, the donor lymphocytic infusion (DLI) was given , and at totals 5 to 6 times for each patient.方法 :采用氟达拉宾、白消安、抗人淋巴细胞球蛋白和骁悉的非清髓性预处理 ,异基因造血干细胞移植 ,移植后 2周开始供者淋巴细胞输注 (DLI) ,每例 5～ 6次 ;应用STR PCR及染色体核型分析检测供者嵌合体 ;每半月～ 1个月监测血型。
5)halotype lymphocyte infusion单倍体淋巴细胞输注
1.In order to observe the curative and side effects in malignant hematologic diseases treated with autologous peripheral blood stem cell transplantation (auto PBSCT) combined with halotype lymphocyte infusion, auto PBSCs were mobilized, harvested and stored at -196℃ from patients in first CR or PR with intensive chemotherapy (Ara C 1.为观察自体外周血干细胞移植联合单倍体淋巴细胞输注治疗恶性血液病的疗效和不良反应 ,对完全缓解或部分缓解的恶性血液病患者用中剂量阿糖胞苷 (1。
6)donor lymphocytes infusion供者淋巴细胞输注
1.Objective To investigate the clonal expansion of T cell receptor (TCR) V? subfamily T cells which were considered as GVL effective cells alter donor lymphocytes infusion ( DLI) in patients with relapse chronic myelogenous leukemia (CML) after allogeneic hone marrow transplantation (allo-BMT).目的 了解供者淋巴细胞输注(DLI)治疗异基因骨髓移植(allo-BMT)后慢性粒细胞白血病(CML)复发患者,产生GVL效应的克隆性TCRVβ亚家族T细胞的情况。
延伸阅读
抗淋巴细胞球蛋白 , 抗淋巴细胞免疫球蛋白,抗人胸腺淋巴细胞球蛋白药物名称：抗淋巴细胞球蛋白英文名：Antilymphocyte Globulin别名：抗淋巴细胞球蛋白 , 抗淋巴细胞免疫球蛋白,抗人胸腺淋巴细胞球蛋白外文名：Antilymphocyte Globuli ,ALG适应症： 1.适用于器官移植时的抗免疫排异治疗。用于人的同种异体移植有明显疗效，特别是对肾脏移植的病人。但也有一定局限性，主要是对急性排异期有效，对体液免疫所致的超急性排异无效。与硫唑嘌呤、泼尼松合用可提高脏器移植的成功率。骨髓移植时，供者与受者双方在术前均给以抗淋巴细胞球蛋白，有防止移植物抗宿主反应的作用。 2.自身免疫性疾病。ＡＬＧ对肾小球肾炎、红斑狼疮、类风湿性关节炎、重症肌无力等自身免疫性疾病有良好疗效，对顽固性皮炎、脉管炎、原发性肝炎、交感性眼炎等也有一定疗效 用量用法： 肌注：马ＡＬＧ每次每千克体重４～２０ｍｇ，兔ＡＬＧ每次每千克体重０．５～１ｍｇ，１日１次或隔日１次，１４日为１疗程。 静注：马ＡＬＧ每次每千克体重７～２０ｍｇ，稀释于５０～１００ｍｌ等渗盐水中，于４～６小时内滴完，输入适量等渗盐水，１日１次。 注意事项： 1.肌注可引起局部疼痛、红肿、发热、荨麻疹等，甚至有过敏性休克，静注也可有短时高热（３８～４０℃，持续３小时）、发冷，有时伴有关节痛和气短。静滴可见一过性体温升高与寒颤、低血压、心率增快等。一般在１～２小时内消退。 2.过敏体质者禁用，有急性感染者慎用。 3.采用ＡＬＧ治疗自身免疫性疾病应特别慎重，因长期应用使机体的免疫监管功能降低，给癌变细胞的发展以可乘之机。规格：冻干粉针剂:25mg(5ml)类别：免疫抑制剂
